7
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T1055 | Ifosfamide | NSC109724,Isophosphamide | DNA Alkylator/Crosslinker , DNA/RNA Synthesis |
Ifosfamide (NSC-109724) alkylates and forms DNA crosslinks, thereby preventing DNA strand separation and DNA replication. Ifosfamide is a synthetic analog of the nitrogen mustard cyclophosphamide with antineoplastic acti... | |||
T25723 | L-Ifosfamide | (+)-Ifosfamide | |
L-Ifosfamide is nitrogen mustard, a chemotherapeutic antineoplastic, and more precisely an alkylating agent structural analog of cyclophosphamide with respect to which presents some differences regard to the antitumor ac... | |||
T4350 | Palifosfamide | ZIO-201,Isophosphamide mustard,Isophosphoramide mustard | DNA Alkylator/Crosslinker , DNA Alkylation , Drug Metabolite |
Palifosfamide (Isophosphamide mustard) lysine (ZIO-201) is a stable form of palifosfamide. Palifosfamide lysine has broad activity in sarcoma lines in vitro. The IC50 ranges from 2.25 to 6.75 μM for most cell lines excep... | |||
T29851 | Aldoifosfamide | UNII-S1JX147O5E,Mitoxana,Ifex | |
Aldoifosfamide is a metabolite of ifosfamide. Ifosfamide (also marketed as Mitoxana and Ifex) is a nitrogen mustard alkylating agent used in the treatment of cancer. It is sometimes abbreviated 'IFO''. | |||
T71500 | Palifosfamide tromethamine | IPM tromethamine,Isophosphoramide mustard tromethamine,ZIO-201 tromethamine,Isophosphoramide mustard tromethamine ; IPM tromethamine ; ZIO-201 tromethamine | |
Palifosfamide (tromethamine), a synthetically derived alkylating agent, exhibits potential antineoplastic properties. Acting as the stabilized active metabolite of ifosfamide, it irreversibly alkylates and crosslinks DNA... | |||
T83317 | 4-Hydroperoxyifosfamide | ||
4-Hydroperoxyifosfamide is an anticancer agent capable of penetrating the blood-brain barrier (BBB) [1]. | |||
T1414 | Sodium 2-mercaptoethanesulfonate | Mitexan,Uromitexan,Mesna,Mesnum,Mesnex | Others |
Sodium 2-mercaptoethanesulfonate (Uromitexan) is a sulfhydryl compound used to prevent urothelial toxicity by inactivating metabolites from antineoplastic agents, such as ifosfamide or cyclophosphamide. |